NMRA   $13.96  -0.57% Market Open

Neumora Therapeutics Inc
Total Cash 371.64M
totalCashPerShare 2.322
EBITDA -230.20M
Total Debt 3.61M
quickRatio 16.141
currentRatio 17.225
Total Revenue
debtToEquity 0.946
Revenue/Share
ROA -0.37750998
ROE -0.77081
grossProfits
freeCashflow -133.95M
operatingCashflow -198.33M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 2.30B
forwardPE -10.761291
floatShares 83.41M
sharesOutstanding 160.03M
sharesShort 9.68M
sharesShortPriorMonth 9.98M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.28%
heldPercentInstitutions 0.61%
Short Ratio help_outline 10.57%
shortPercentOfFloat 0.12%
impliedSharesOutstanding
bookValue 2.384
Price To Book help_outline 7.00
earningsQuarterlyGrowth
netIncomeToCommon -274.18M
trailingEps -1.79%
forwardEps -1.55%
enterpriseToEbitda -10.00
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.39 3Q 2024
institutionsCount 135
lastUpdated Oct. 17, 2024, 12:34 p.m.